Moreover, reports have established that a urinary exosome‐derived lncRNA panel (MALAT1, PCAT‐1, and SPRY4‐IT1) could be used as noninvasive diagnostic and prognostic biomarker of BC with considerable clinical value. This evidence concerns the gene PCAT1 and breast cancer.